Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.5 HKD | -1.96% | -3.85% | -24.24% |
Apr. 22 | Lexeo Therapeutics Signs License Deal With Cornell for Potential Friedreich Ataxia Cardiomyopathy Drug | MT |
Apr. 17 | Future Data Group Limited Announces Changes to its Board | CI |
Sales 2021 | 721M 92.23M | Sales 2022 | 618M 79.05M | Capitalization | 156M 19.97M |
---|---|---|---|---|---|
Net income 2021 | 7M 896K | Net income 2022 | -3M -384K | EV / Sales 2021 | 0.1 x |
Net cash position 2021 | 35.36M 4.53M | Net cash position 2022 | 56.95M 7.29M | EV / Sales 2022 | 0.16 x |
P/E ratio 2021 |
14.9
x | P/E ratio 2022 |
-50.3
x | Employees | 243 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 45.25% |
1 day | -1.96% | ||
1 week | -3.85% | ||
Current month | -1.96% | ||
1 month | +5.26% | ||
3 months | -7.41% | ||
6 months | -38.27% | ||
Current year | -24.24% |
Managers | Title | Age | Since |
---|---|---|---|
Seung-Han Lee
FOU | Founder | 53 | 16-06-30 |
Ting Pong Cheung
CEO | Chief Executive Officer | 44 | 23-05-15 |
Yuk Kan Lo
CTO | Chief Tech/Sci/R&D Officer | - | 23-08-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Hong Xia Tao
CHM | Chairman | 50 | 22-10-30 |
Ting Pong Cheung
CEO | Chief Executive Officer | 44 | 23-05-15 |
Seung-Han Lee
FOU | Founder | 53 | 16-06-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 0.5 | -1.96% | 625,000 |
24-05-09 | 0.51 | 0.00% | 645,000 |
24-05-08 | 0.51 | 0.00% | 695,000 |
24-05-07 | 0.51 | +2.00% | 680,000 |
24-05-06 | 0.5 | -3.85% | 740,000 |
Delayed Quote Hong Kong S.E., May 10, 2024 at 04:08 am EDT
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-24.24% | 34.98M | |
+3.96% | 35.43B | |
+3.03% | 15.57B | |
-7.82% | 8.85B | |
+3.01% | 7.28B | |
-44.61% | 4.56B | |
+8.74% | 2.92B | |
-13.78% | 2.36B | |
+2.77% | 2.34B | |
-16.50% | 2.04B |
- Stock Market
- Equities
- 8229 Stock